Case report reveals allergic bronchopulmonary aspergillosis in a child with recurrent pneumonia, suggesting IgE screening importance.
Allergic bronchopulmonary aspergillosis (ABPA), a hypersensitivity lung disease mediated by Aspergillus fumigatus , represents a frequently overlooked diagnosis in pediatric practice. We describe an 11-year-old girl with difficult-to-treat asthma and recurrent pneumonias (three episodes within one year) in whom comprehensive evaluation revealed borderline total IgE (678 IU/mL), Aspergillus -specific IgE of 5.81 kUA/L, high-resolution CT demonstrating bilateral infiltrates with scattered nodules, and Aspergillus fumigatus identification via bronchoalveolar lavage fluid culture and targeted next-generation sequencing (tNGS). Initiation of systemic corticosteroids plus itraconazole produced rapid clinical resolution within three weeks, decreased total IgE by 29% (to 479 IU/mL) at one month, and achieved marked radiographic improvement by four months. This case highlights the need to consider ABPA in children with difficult-to-treat asthma and recurrent pulmonary infections, suggests Aspergillus -specific IgE screening in difficult-to-treat asthma, while diagnosis should rely on integrated clinical, immunologic, radiologic, and microbiologic assessment.
No takes yet. Share an insight, caveat, or question.
Ying et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: